New Device for the Treatment of Functional Ischemic Mitral Regurgitation: Proof of Concept in an In Vitro ModelFunding No funding from extern sources was received for this study.
09 April 2018
20 August 2018
08 October 2018 (online)
Background Optimal surgical treatment of functional ischemic mitral regurgitation (FIMR) is still controversy. Due to the underlying pathophysiology, stand-alone ring annuloplasty is assumed with a high recurrence rate of mitral regurgitation, thus additional subvalvular repair techniques might improve the results. This in vitro study introduces a new device for subvalvular mitral valve repair.
Methods We developed a new device for subvalvular mitral valve repair, consisting of two frames for papillary muscle (PM) attachment, which are connected with two holding bars serving for fixation of the device on an annuloplasty ring. In the first experimental run, porcine mitral valves including the chordae tendineae and PMs were fixated on a holding device, consisting of a holding ring simulating mitral annulus dilation and height-adjustable frames for PM attachment simulating leaflet tethering. In vitro regurgitant volume was determined in a pulse duplicator. Afterward, the frames for PM attachment were replaced by our newly developed device and the measurements were repeated.
Results In the model simulating FIMR, the regurgitant volume was 44.3 ± 12.38 mL/stroke. After subvalvular reconstruction with our new device, the regurgitant volume was significantly reduced to 33.1 ± 11.68 mL/stroke (p = 0.009).
Conclusion In this specific in vitro model, our new device for subvalvular mitral valve reconstruction led to a significant reduction of the regurgitant volume, thus representing a promising technique to potentially improve the results of mitral reconstruction in ischemic functional mitral valve regurgitation. Additional studies are required to further investigate and improve our device.
- 1 Fino C, Iacovoni A, Ferrero P. , et al. Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2015; 149 (06) 1595-1603
- 2 Kuwahara E, Otsuji Y, Iguro Y. , et al; American Heart Association. Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation 2006; 114 (1, Suppl): I529-I534
- 3 McGee EC, Gillinov AM, Blackstone EH. , et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004; 128 (06) 916-924
- 4 Zhu F, Otsuji Y, Yotsumoto G. , et al. Mechanism of persistent ischemic mitral regurgitation after annuloplasty: importance of augmented posterior mitral leaflet tethering. Circulation 2005; 112 (9, Suppl): I396-I401
- 5 Digiammarco G, Liberi R, Giancane M. , et al. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it. Interact Cardiovasc Thorac Surg 2007; 6 (03) 340-344
- 6 Gelsomino S, Lorusso R, De Cicco G. , et al. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J 2008; 29 (02) 231-240
- 7 Goldstein D, Moskowitz AJ, Gelijns AC. , et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 2016; 374: 344-353
- 8 Baumgartner H, Falk V, Bax JJ. , et al; ESC Scientific Document Group. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017; 38 (36) 2739-2791
- 9 Nishimura RA, Otto CM, Bonow RO. , et al; American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014; 148 (01) e1-e132
- 10 Scharfschwerdt M, Misfeld M, Sievers H-H. The influence of a nonlinear resistance element upon in vitro aortic pressure tracings and aortic valve motions. ASAIO J 2004; 50 (05) 498-502
- 11 Lancellotti P, Moura L, Pierard LA. , et al; European Association of Echocardiography. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11 (04) 307-332
- 12 Lancellotti P, Troisfontaines P, Toussaint A-C, Pierard LA. ; American Heart Association. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 2003; 108 (14) 1713-1717
- 13 Rabbah J-PM, Siefert AW, Bolling SF, Yoganathan AP. Mitral valve annuloplasty and anterior leaflet augmentation for functional ischemic mitral regurgitation: quantitative comparison of coaptation and subvalvular tethering. J Thorac Cardiovasc Surg 2014; 148 (04) 1688-1693
- 14 Malhotra A, Sharma P, Garg P, Bishnoi A, Kothari J, Pujara J. Ring annuloplasty for ischemic mitral regurgitation: a single center experience. Asian Cardiovasc Thorac Ann 2014; 22 (07) 781-786
- 15 Mihos CG, Larrauri-Reyes M, Santana O. A meta-analysis of ring annuloplasty versus combined ring annuloplasty and subvalvular repair for moderate-to-severe functional mitral regurgitation. J Card Surg 2016; 31 (01) 31-37
- 16 Athanasopoulos LV, Moscarelli M, Speziale G, Punjabi PP, Athanasiou T. Are adjunct subvalvular techniques more effective than isolated restrictive annuloplasty for treating ischemic mitral regurgitation?. Perfusion 2017; 32 (02) 92-96
- 17 Nappi F, Lusini M, Spadaccio C. , et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol 2016; 67 (20) 2334-2346
- 18 Girdauskas E, Conradi L, Harmel EK, Reichenspurner H. Minimally invasive mitral valve annuloplasty with realignment of both papillary muscles for correction of type IIIb functional mitral regurgitation. Innovations (Phila) 2017; 12 (05) 329-332
- 19 Langer F, Kunihara T, Hell K. , et al; American Heart Association. RING+STRING: successful repair technique for ischemic mitral regurgitation with severe leaflet tethering. Circulation 2009; 120 (11, Suppl): S85-S91
- 20 Fattouch K, Castrovinci S, Murana G. , et al. Papillary muscle relocation and mitral annuloplasty in ischemic mitral valve regurgitation: midterm results. J Thorac Cardiovasc Surg 2014; 148 (05) 1947-1950
- 21 Watanabe T, Arai H, Nagaoka E. , et al. Influence of procedural differences on mitral valve configuration after surgical repair for functional mitral regurgitation: in which direction should the papillary muscle be relocated?. J Cardiothorac Surg 2014; 9: 185
- 22 Pingpoh C, Siepe M, Bothe W. Surgical treatment of secondary mitral regurgitation: is repair a reasonable option?. J Vis Surg 2017; 3: 158
- 23 Lomholt M, Nielsen SL, Hansen SB, Andersen NT, Hasenkam JM. Differential tension between secondary and primary mitral chordae in an acute in-vivo porcine model. J Heart Valve Dis 2002; 11 (03) 337-345
- 24 Obadia JF, Casali C, Chassignolle JF, Janier M. Mitral subvalvular apparatus: different functions of primary and secondary chordae. Circulation 1997; 96 (09) 3124-3128
- 25 Calafiore AM, Refaie R, Iacò AL. , et al. Chordal cutting in ischemic mitral regurgitation: a propensity-matched study. J Thorac Cardiovasc Surg 2014; 148 (01) 41-46
- 26 Robb JD, Minakawa M, Koomalsingh KJ. , et al. Posterior leaflet augmentation improves leaflet tethering in repair of ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011; 40 (06) 1501-1507 , discussion 1507
- 27 Jassar AS, Minakawa M, Shuto T. , et al. Posterior leaflet augmentation in ischemic mitral regurgitation increases leaflet coaptation and mobility. Ann Thorac Surg 2012; 94 (05) 1438-1445